94 related articles for article (PubMed ID: 9665198)
21. Mutations in the tumor suppressors Smad2 and Smad4 inactivate transforming growth factor beta signaling by targeting Smads to the ubiquitin-proteasome pathway.
Xu J; Attisano L
Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4820-5. PubMed ID: 10781087
[TBL] [Abstract][Full Text] [Related]
22. Mutations of the DPC4/Smad4 gene in neuroendocrine pancreatic tumors.
Bartsch D; Hahn SA; Danichevski KD; Ramaswamy A; Bastian D; Galehdari H; Barth P; Schmiegel W; Simon B; Rothmund M
Oncogene; 1999 Apr; 18(14):2367-71. PubMed ID: 10327057
[TBL] [Abstract][Full Text] [Related]
23. HSNF5/INI1 gene mutations in lymphoid malignancy.
Yuge M; Nagai H; Uchida T; Murate T; Hayashi Y; Hotta T; Saito H; Kinoshita T
Cancer Genet Cytogenet; 2000 Oct; 122(1):37-42. PubMed ID: 11104031
[TBL] [Abstract][Full Text] [Related]
24. Mutation analysis of the Smad2 gene in human colon cancers using genomic DNA and intron primers.
Takenoshita S; Tani M; Mogi A; Nagashima M; Nagamachi Y; Bennett WP; Hagiwara K; Harris CC; Yokota J
Carcinogenesis; 1998 May; 19(5):803-7. PubMed ID: 9635866
[TBL] [Abstract][Full Text] [Related]
25. Infrequent mutations in the P53 gene in primary human T-cell acute lymphoblastic leukemia.
Jonveaux P; Berger R
Leukemia; 1991 Oct; 5(10):839-40. PubMed ID: 1961018
[TBL] [Abstract][Full Text] [Related]
26. [Alterations in DPC4 gene in pancreatic cancers].
Gu L; Chen J; Cui Q
Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):293-5. PubMed ID: 11783110
[TBL] [Abstract][Full Text] [Related]
27. Mechanism for mutational inactivation of the tumor suppressor Smad2.
Prunier C; Ferrand N; Frottier B; Pessah M; Atfi A
Mol Cell Biol; 2001 May; 21(10):3302-13. PubMed ID: 11313456
[TBL] [Abstract][Full Text] [Related]
28. Combined copy status of 18q21 genes in colorectal cancer shows frequent retention of SMAD7.
Boulay JL; Mild G; Reuter J; Lagrange M; Terracciano L; Lowy A; Laffer U; Orth B; Metzger U; Stamm B; Martinoli S; Herrmann R; Rochlitz C
Genes Chromosomes Cancer; 2001 Jul; 31(3):240-7. PubMed ID: 11391794
[TBL] [Abstract][Full Text] [Related]
29. TGF-beta-induced nuclear localization of Smad2 and Smad3 in Smad4 null cancer cell lines.
Fink SP; Mikkola D; Willson JK; Markowitz S
Oncogene; 2003 Mar; 22(9):1317-23. PubMed ID: 12618756
[TBL] [Abstract][Full Text] [Related]
30. DCC and SMAD4 alterations in human colorectal and pancreatic tumor dissemination.
Tarafa G; Villanueva A; Farré L; Rodríguez J; Musulén E; Reyes G; Seminago R; Olmedo E; Paules AB; Peinado MA; Bachs O; Capellá G
Oncogene; 2000 Jan; 19(4):546-55. PubMed ID: 10698524
[TBL] [Abstract][Full Text] [Related]
31. Mutations of the Smad4 gene in acute myelogeneous leukemia and their functional implications in leukemogenesis.
Imai Y; Kurokawa M; Izutsu K; Hangaishi A; Maki K; Ogawa S; Chiba S; Mitani K; Hirai H
Oncogene; 2001 Jan; 20(1):88-96. PubMed ID: 11244507
[TBL] [Abstract][Full Text] [Related]
32. The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function.
Zhang Y; Musci T; Derynck R
Curr Biol; 1997 Apr; 7(4):270-6. PubMed ID: 9094310
[TBL] [Abstract][Full Text] [Related]
33. DPC4 gene in various tumor types.
Schutte M; Hruban RH; Hedrick L; Cho KR; Nadasdy GM; Weinstein CL; Bova GS; Isaacs WB; Cairns P; Nawroz H; Sidransky D; Casero RA; Meltzer PS; Hahn SA; Kern SE
Cancer Res; 1996 Jun; 56(11):2527-30. PubMed ID: 8653691
[TBL] [Abstract][Full Text] [Related]
34. Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta.
Feng XH; Lin X; Derynck R
EMBO J; 2000 Oct; 19(19):5178-93. PubMed ID: 11013220
[TBL] [Abstract][Full Text] [Related]
35. Mutational analysis of the candidate tumor suppressor genes TEL and KIP1 in childhood acute lymphoblastic leukemia.
Stegmaier K; Takeuchi S; Golub TR; Bohlander SK; Bartram CR; Koeffler HP
Cancer Res; 1996 Mar; 56(6):1413-7. PubMed ID: 8640833
[TBL] [Abstract][Full Text] [Related]
36. Mutations increasing autoinhibition inactivate tumour suppressors Smad2 and Smad4.
Hata A; Lo RS; Wotton D; Lagna G; Massagué J
Nature; 1997 Jul; 388(6637):82-7. PubMed ID: 9214507
[TBL] [Abstract][Full Text] [Related]
37. Differential expression of a novel C-terminally truncated splice form of SMAD5 in hematopoietic stem cells and leukemia.
Jiang Y; Liang H; Guo W; Kottickal LV; Nagarajan L
Blood; 2000 Jun; 95(12):3945-50. PubMed ID: 10845932
[TBL] [Abstract][Full Text] [Related]
38. The 18q21 region in colorectal and pancreatic cancer: independent loss of DCC and DPC4 expression.
Barberá VM; Martín M; Mariñoso L; Munné A; Carrato A; Real FX; Fabre M
Biochim Biophys Acta; 2000 Oct; 1502(2):283-96. PubMed ID: 11040453
[TBL] [Abstract][Full Text] [Related]
39. Allelic analysis of serous ovarian carcinoma reveals two putative tumor suppressor loci at 18q22-q23 distal to SMAD4, SMAD2, and DCC.
Lassus H; Salovaara R; Aaltonen LA; Butzow R
Am J Pathol; 2001 Jul; 159(1):35-42. PubMed ID: 11438451
[TBL] [Abstract][Full Text] [Related]
40. Alterations of the p53, p21, p16, p15 and RAS genes in childhood T-cell acute lymphoblastic leukemia.
Kawamura M; Ohnishi H; Guo SX; Sheng XM; Minegishi M; Hanada R; Horibe K; Hongo T; Kaneko Y; Bessho F; Yanagisawa M; Sekiya T; Hayashi Y
Leuk Res; 1999 Feb; 23(2):115-26. PubMed ID: 10071127
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]